The importance of intraoperative fluid balance for the prevention of postoperative acute exacerbation of idiopathic pulmonary fibrosis after pulmonary resection for primary lung cancer

European Journal of Cardio-thoracic Surgery

Volumn 41, Issue 6, 2012, Pages

  Mizuno, Yoshimasa ^a   Iwata, Hisashi ^a   Shirahashi, Koyo ^a   Takamochi, Kazuya ^b   Oh, Shiaki ^a   Suzuki, Kenji ^a   Takemura, Hirofumi ^b  

^a GIFU UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Fluid management; Idiopathic pulmonary fibrosis; Postoperative exacerbation; Primary lung cancer; Pulmonary resection

Indexed keywords

C REACTIVE PROTEIN; BIOLOGICAL MARKER;

AGED; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; FIBROSING ALVEOLITIS; FLUID BALANCE; HUMAN; LOBECTOMY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; RISK ASSESSMENT; WEIGHT GAIN; ACUTE DISEASE; BLOOD; CLINICAL TRIAL; ELECTROLYTE BALANCE; FLUID THERAPY; LUNG RESECTION; LUNG TUMOR; METABOLISM; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PEROPERATIVE CARE; PHYSIOLOGY; PROGNOSIS; RISK FACTOR;

ACUTE DISEASE; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; FLUID THERAPY; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; INTRAOPERATIVE CARE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PNEUMONECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; WATER-ELECTROLYTE BALANCE;

EID: 84865357476     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezs147     Document Type: Article

References (21)

1. Behr J, Kolb M, Cox G. Treating IPF-all or nothing? A PRO-CON debate. Respirology 2009;14:1072-81.
2. Kawasaki H, Nagai K, Yokose T, Yoshida J, Nishimura M, Takahashi K et al. Clinicopathological characteristics of surgically resected lung cancer associated with idiopathic pulmonary fibrosis. J Surg Oncol 2001;76:53-7.
3. Hubbard R, Venn A, Lewis S, Britton J. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am J Respir Crit Care Med 2000;161:5-8.
4. Koizumi K, Hirata T, Hirai K, Mikami I, Okada D, Yamagishi S et al. Surgical treatment of lung cancer combined with interstitial pneumonia: the effect of surgical approach on postoperative acute exacerbation. Ann Thorac Cardiovasc Surg 2004;10:340-6.
5. Watanabe A, Higami T, Ohori S, Koyanagi T, Nakashima S, Mawatari T. Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis? J Thorac Cardiovasc Sur 2008;136:1357-63.
6. Okamoto T, Gotoh M, Masuya D, Nakashima T, Liu D, Kameyama K et al. Clinical analysis of interstitial pneumonia after surgery for lung cancer. Jpn J Thorac Cardiovasc Surg 2004;52:323-9.
7. Shintani Y, Ohta M, Iwasaki T, Ikeda N, Tomita E, Kawahara K et al. Predictive factors for postoperative acute exacerbation of interstitial pneumonia combined with lung cancer. Gen Thorac Cardiovasc Surg 2010;58:182-5.
8. Kumar P, Goldstraw P, Yamada K, Nicholson AG, Wells AU, Hansell DM et al. Pulmonary fibrosis and lung cancer: risk and benefit analysis of pulmonary resection. J Thorac Cardiovasc Surg 2003;125:1321-7.
9. Licker M, de Perrot M, Spiliopoulos A, Robert J, Diaper J, Chevalley C et al. Risk factors for acute lung injury after thoracic surgery for lung cancer. Anesth Analg 2003;97:1558-65.
10. Licker M, Diaper J, Villiger Y, Spiliopoulos A, Licker V, Robert J et al. Impact of intraoperative lung-protective interventions in patients undergoing lung cancer surgery. Crit Care 2009;13:R41.
11. Eichenbaum KD, Neustein SM. Acute lung injury after thoracic surgery. J Cardiothorac Vasc Anesth 2010;24:681-90.
12. American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002;165:277-304.
13. Kondoh Y, Taniguchi H, Kawabata Y, Yokoi T, Suzuki K, Takagi K.Acute exacerbation in idiopathic pulmonary fibrosis. Analysis of clinical and pathologic findings in three cases. Chest 1993;103:1808-12.
14. Sakata R, Fujii Y, Kuwano H. Thoracic and cardiovascular surgery in Japan during 2008: annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 2010;58:356-83.
15. Fujimoto T, Okazaki T, Matsukura T, Hanawa T, Yamashita N, Nishimura K et al. Operation for lung cancer in patients with idiopathic pulmonary fibrosis: surgical contraindication? Ann Thorac Surg 2003; 76:1674-8.
16. Chiyo M, Sekine Y, Iwata T, Tatsumi K, Yasufuku K, Iyoda A et al. Impact of interstitial lung disease on surgical morbidity and mortality for lung cancer: analyses of short-term and long-term outcomes. J Thorac Cardiovasc Surg 2003;126:1141-6.
17. Minegishi Y, Sudoh J, Kuribayasi H, Mizutani H, Seike M, Azuma A et al. The safety and efficacy of weekly paclitaxel in combination with carboplatin for advanced non-small cell lung cancer with idiopathic interstitial pneumonias. Lung Cancer 2011;71:70-4.
18. Takeda A, Enomoto T, Sanuki N, Nakajima T, Takeda T, Sayama K et al. Acute exacerbation of subclinical idiopathic pulmonary fibrosis triggered by hypofractionated stereotactic body radiotherapy in a patient with primary lung cancer and slightly focal honeycombing. Radiat Med 2008; 26:504-7.
19. Akiba T, Marushima H, Kawahara H, Takagi M, Hirano J, Odaka M et al. Video-assisted thoracic surgery for patients with lung cancer and interstitial pneumonia. Ann Thorac Cardiovasc Surg 2010;16: 236-41.
20. Della Rocca G, Coccia C. Ventilatory management of one-lung ventilation. Minerva Anestesiol 2011;77:534-6.
21. Diaper J, Ellenberger C, Villiger Y, Robert J, Tschopp JM, Licker M. Transoesophageal Doppler monitoring for fluid and hemodynamic treatment during lung surgery. J Clin Monit Comput 2008;22:367-74.